Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
356.05
-0.85 (-0.24%)
BSENSE

Jul 30, 01:13 PM

BSE+NSE Vol: 9.49 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Novartis India
IOL Chemicals
RPG LifeScience.
Bliss GVS Pharma
Gufic BioScience
Advanced Enzyme
Guj. Themis Bio.
Aarti Drugs
Unichem Labs.
SMS Pharma.
Zota Health Care

Why is Gujarat Themis Biosyn Ltd ?

1
High Management Efficiency with a high ROE of 29.26%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.14 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.86% and Operating profit at 10.16% over the last 5 years
4
Negative results in Mar 26
  • ROCE(HY) Lowest at 14.47%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 10.75 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.72 times
5
With ROCE of 14.1, it has a Very Expensive valuation with a 9.1 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -8.26%, its profits have fallen by -4.3%
6
68.49% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
  • The proportion of pledged holdings has increased by 63.05% over the last quarter
7
Below par performance in long term as well as near term
  • Along with generating -8.26% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Guj. Themis Bio. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guj. Themis Bio. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Guj. Themis Bio.
-8.36%
-0.17
50.09%
Sensex
-4.61%
-0.33
13.57%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.86%
EBIT Growth (5y)
10.16%
EBIT to Interest (avg)
57.37
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0.54
Sales to Capital Employed (avg)
0.82
Tax Ratio
24.83%
Dividend Payout Ratio
14.97%
Pledged Shares
68.49%
Institutional Holding
2.94%
ROCE (avg)
41.80%
ROE (avg)
29.26%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
84
Industry P/E
37
Price to Book Value
13.55
EV to EBIT
64.78
EV to EBITDA
53.70
EV to Capital Employed
9.15
EV to Sales
24.46
PEG Ratio
NA
Dividend Yield
0.19%
ROCE (Latest)
14.12%
ROE (Latest)
16.22%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NET SALES(Q)

Highest at Rs 44.23 cr

-11What is not working for the Company
ROCE(HY)

Lowest at 14.47%

INVENTORY TURNOVER RATIO(HY)

Lowest at 10.75 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.72 times

PBT LESS OI(Q)

At Rs 13.42 cr has Fallen at -12.0% (vs previous 4Q average

PAT(Q)

At Rs 10.89 cr has Fallen at -8.8% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is working for Guj. Themis Bio.

Net Sales - Quarterly
Highest at Rs 44.23 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Guj. Themis Bio.

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 13.42 cr has Fallen at -12.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 15.25 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Inventory Turnover Ratio- Half Yearly
Lowest at 10.75 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 2.72 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Profit After Tax (PAT) - Quarterly
At Rs 10.89 cr has Fallen at -8.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 11.95 Cr
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)